Newly approved cervical cancer drug Tivdak gives patients a new option
The BioWorld Insider Podcast09/24/21 • 18 min
The approval of antibody-drug conjugate Tivdak (tisotumab vedotin) for treating cervical cancer and the future of Genmab A/S are the subjects with the company's president and CEO, Jan van de Winkel.
Hosted on Acast. See acast.com/privacy for more information.
09/24/21 • 18 min
Generate a badge
Get a badge for your website that links back to this episode
Select type & size
<a href="https://goodpods.com/podcasts/the-bioworld-insider-podcast-377776/newly-approved-cervical-cancer-drug-tivdak-gives-patients-a-new-option-53974783"> <img src="https://storage.googleapis.com/goodpods-images-bucket/badges/generic-badge-1.svg" alt="listen to newly approved cervical cancer drug tivdak gives patients a new option on goodpods" style="width: 225px" /> </a>
Copy